Interactions between thyroid disorders and kidney disease

Gopal Basu1, Anjali Mohapatra

  • 1Department of Nephrology, Christian Medical College, Vellore, Tamil Nadu, India.

Insights

Thyroid hormones significantly impact kidney function, influencing blood flow and filtration. Understanding these thyroid-kidney interactions is crucial for managing patients with kidney disease and thyroid dysfunction.

Area of Science:

  • Nephrology and Endocrinology
  • Physiology and Pathophysiology of Thyroid and Kidney

Background:

  • Thyroid hormones play a critical role in renal development and physiological functions.
  • Thyroid dysfunction is prevalent in chronic kidney disease (CKD) patients, often presenting as low T3 syndrome or primary/subclinical hypothyroidism.

Purpose of the Study:

  • To elucidate the complex interactions between thyroid function and kidney health across various disease states.
  • To highlight the clinical implications for managing patients with co-existing thyroid and renal conditions.

Main Methods:

  • Review of existing literature on thyroid-kidney interactions.
  • Analysis of physiological effects of thyroid hormones on renal parameters like GFR and renal blood flow.
  • Examination of the association between thyroid dysfunction and CKD, glomerulonephritis, and malignancies.

Main Results:

  • Hypothyroidism is linked to reduced GFR, while hyperthyroidism is associated with increased GFR and renin-angiotensin-aldosterone system activation.
  • CKD is characterized by low T3 syndrome and a higher incidence of hypothyroidism.
  • Thyroid dysfunction can be associated with glomerulonephritis, often due to shared autoimmune causes.

Conclusions:

  • A conservative treatment approach for thyroid abnormalities in CKD is recommended due to the potential benefits of a hypothyroid state and risks of hyperthyroidism.
  • Awareness of drug interactions affecting both thyroid and kidney function is essential.
  • Comprehensive understanding of thyroid-kidney interactions is vital for nephrologists and endocrinologists.

Related Concept Videos

Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...